Exact Sciences (EXAS)
BiotechSign Signal Grade
Composite of clinical trial activity, dilution exposure, publications, short interest, and insider transactions — all from verified public filings.
Pipeline Overview
- Therapeutic Focus
- Diagnosticssrc
Clinical Trial Activity
(ClinicalTrials.gov aggregate)
ClinicalTrials.gov aggregate as of 2026-10-12. ClinicalTrials.gov
Dilution Risk
LOW DILUTION RISKDilution score: 14/100 (LOW), 43.9 months cash
Derived from verified regulatory filings. Measures dilution exposure from warrants, convertibles, and offering history. DilutionWatch SEC-derived score
Short Interest
Short interest: 4.0% of float, squeeze risk: MODERATE
FINRA short sale data. FINRA short interest
Recent News & SEC Filings
- SEC 8-K 8-K - Current report
- SEC 8-K 8-K - Current report
- SEC 8-K 8-K - Current report
- SEC 8-K 8-K - Current report
- SEC 8-K 8-K - Current report
Headlines from public sources. BiotechSign does not endorse or verify linked content.
Recent Publications
- Quantitative electroencephalographic comparison of intranasal midazolam, intranasal saline, and intrarectal diazepam in healthy dogs: A two-session, fixed-order pilot study. — Vet J 2026 Sep 21 PMID 42767485
- Inter-rater reliability in drug-induced sleep endoscopy: experience-driven interpretation, decision-making, and the emerging role of artificial intelligence. — Sleep Breath 2026 Sep 21 PMID 42766212
- Efficacy, safety and circulating tumor cell dynamics in patients treated with Eribulin for HER2-negative advanced breast cancer - results from the phase II DETECT IVb trial. — Breast Cancer Res Treat 2026 Sep 16 PMID 42747616
- APOE-stratified genome-wide association analyses provide insights into the genetic etiology of Alzheimers's disease. — Nat Genet 2026 Sep 14 PMID 42736378
- Second ipsilateral locoregional recurrence in patients with hormone receptor-positive, HER2-negative breast cancer: a cohort study. — EClinicalMedicine 2026 Sep PMID 42729525
Get real-time catalyst alerts, analyst signals, dilution risk tracking, and full pipeline data for Exact Sciences.
Full EXAS Dashboard Sign Up FreePrimary Sources
This page reports only records present in the BiotechSign source payload as of the generation date. It does not infer drug efficacy, clinical outcome probability, approval odds, revenue, market size, or unreported regulatory events.